IDT Australia Cuts EBITDA Loss 84% to $436K as API Revenue Surges 191%

By

Key Takeaways

IDT Australia reports H1 FY26 turnaround with EBITDA loss narrowing 84% to $436K, API manufacturing surging 191%, and cost savings target doubled to $2M as the company targets positive operating profit.

  • IDT Australia's 84% EBITDA improvement to a $436K loss demonstrates the strategic reset under new leadership is delivering measurable results
  • API manufacturing's 191% revenue surge creates a sales funnel for higher-margin Specialty Orals and Sterile Fill follow-on work
  • Exposure to mRNA (US$26.1B by 2034) and radiopharmaceutical (US$21.9B by 2029) markets provides structural growth tailwinds
  • Management targets positive operating profit in the near term with solid pipeline across all business units

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher